Lv31
390 积分 2024-11-27 加入
C-Reactive Protein-to-Albumin Ratio to Predict Tolerability of S-1 as an Adjuvant Chemotherapy in Pancreatic Cancer
2小时前
已完结
High γ‐H2AX Predicts Clinical Benefit From Platinum‐Based Chemotherapy (mFOLFIRINOX) at Recurrence After Pancreatic Cancer Resection
2个月前
已完结
Randomized clinical trial of adjuvant chemotherapy with S-1 versus gemcitabine after pancreatic cancer resection
2个月前
已完结
Survival outcomes of adjuvant chemotherapy in patients with stage I pancreatic cancer stratified by pathologic risk
2个月前
已完结
Preoperative Serum Total Cholesterol Predicts Adjuvant Chemotherapy Completion After Pancreaticoduodenectomy for Pancreatic Cancer
2个月前
已完结
Effect of adjuvant chemotherapy after pancreatectomy in patients with node-negative pancreatic cancer: target trial emulation
2个月前
已完结
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question—Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head
2个月前
已完结
Poor Prognostic Factors in Long-Term Survivors of Resected Pancreatic Ductal Adenocarcinoma
2个月前
已完结
The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma – A systematic review and meta-analysis
2个月前
已完结
Adjuvant Treatment for Resectable Pancreatic Cancer
2个月前
已完结
皖公网安备34019202002308
